Blood Loss and Transfusion Requirement in Infants Treated With Tranexamic Acid
Status:
Suspended
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to investigate whether tranexamic acid (TXA) reduces
perioperative blood loss and transfusion requirement in infants undergoing craniosynostosis
surgery.